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The ATPase associated with different cellular activities family
member p97, associated p47, and the t-SNARE syntaxin 5 are
necessary for the cell-free reconstitution of transitional endoplas-
mic reticulum (tER) from starting low-density microsomes. Here,
we report that membrane-associated tyrosine kinase and protein-
tyrosine phosphatase (PTPase) activities regulate tER assembly by
stabilizing (PTPase) or destabilizing (tyrosine kinase) p97 associa-
tion with membranes. Incubation with the PTPase inhibitor bpV-
(phen) inhibited tER assembly coincident with the enhanced ty-
rosine phosphorylation of endogenous p97 and its release from
membranes. By contrast, the tyrosine kinase inhibitor, genistein,
promoted tER formation and prevented p97 dissociation from
membranes while increasing p97 association with the t-SNARE
syntaxin 5. Purification of the endogenous tyrosine kinase activity
from low-density microsomes led to the identification of JAK-2,
whereas PTPH1 was identified as the relevant PTPase. The p97
tyrosine phosphorylation state is proposed to coordinate the
assembly of the tER as a regulatory step of the early secretory
pathway.
The endoplasmic reticulum (ER)-Golgi transitional elementsconsist essentially of two types. The first type, composed of
vesicular tubular clusters, has been described as a pre-Golgi
intermediate, which is physically distinct from the ER, and which
acts as a transport vehicle for protein delivery to the Golgi
complex (1–6, 38). The second type, composed of a network of
smooth tubules in continuity with the rough ER, is known to vary
widely within different cell types. It has been described as a
compartment functioning as an exit site for biosynthetic material
shuttling between the ER and the Golgi complex or the ER and
the intermediate compartment. The latter type of intermediate
compartment includes the budding compartment of mouse
hepatitis virus (7), the site of accumulation of the E1 glycopro-
tein of the rubella virus (8), and the site of accumulation of
vesicular stomatitis virus glycoproteins in cells injected with
anti-b-coatomer protein (9). Transitional ER (tER) membrane
networks consisting of anastomosing smooth tubules continuous
with rough membrane cisternae have been reconstituted in vitro
(10–12) and were shown to have similar morphological and
biochemical characteristics to the transitional element described
above.
The ATPase associated with different cellular activities
ATPase p97 was shown to regulate membrane fusion and
assembly of tER in vitro (12). In addition, p97 was observed to
dissociate from the ER membranes during tER assembly (12).
The size of the tER membrane networks assembled in this
cell-free system was constant (10). This suggested an additional
regulatory step, wherein modulation of the number of rounds of
fusion limited the size of the tER compartment. P97 membrane
association was suspected as the regulatory step with phosphor-
ylation of p97 as the trigger.
In both the budding yeast Saccharomyces cerevisiae and mam-
malian WISH cells, cdc48pyp97 tyrosine phosphorylation (13)
coincides with its relocalization from the ER to the nucleus
(yeast) or to the centrosome (mammalian WISH cells). Tyrosine
phosphorylation of p97 in T cells has been observed as a
consequence of p60fyn overexpression as well as treatment of
these cells with protein-tyrosine phosphatase (PTPase) inhibi-
tors (14). In addition, in activated B lymphocytes, p97 becomes
tyrosine phosphorylated after treatment with the PTPase inhib-
itor, sodium vanadate (15). Moreover, p97 is the major substrate
of the protein-tyrosine phosphatase PTPH1 (16), and overex-
pression of PTPH1 in NIH 3T3 cells leads to p97 dephosphor-
ylation coinciding with an inhibition of cell-cycle progression and
the accumulation of cells throughout the cell cycle (16).
Here, we demonstrate that a cycle of tyrosine phosphorylation
and dephosphorylation of p97 regulates p97 association with the
t-SNARE syntaxin 5 and subsequent membrane fusion in a
cell-free system, which reconstitutes tER formation. We also
identify the candidate tyrosine kinase and phosphotyrosine
phosphatase as JAK-2 and PTPH-1, respectively.
Experimental Procedures
Materials. Anti-p97 was a kind gift of R. Hendricks (EMBL,
Germany). Purified rat p97 was generously provided by J.
Lanoix and T. Nilsson (EMBL, Germany). Anti-Bip and
anti-JAK-2 were kindly given by L. Hendershot and J. Ihle,
respectively (St. Jude Children’s Research Hospital, Memphis,
TN). Anti-syntaxin 5 antibodies were kindly provided by W.
Hong (Institute of Molecular and Cell Biology, Singapore).
Anti-PTPH1 antibodies and GST-PTPH1 constructs were
described previously (16).
Analytical Fractionation and in Vitro Reconstitution of Transitional ER.
Subfractions enriched in rough and smooth vesicles were ob-
tained from a step-gradient of sucrose used to separate rough
microsomes, low-density microsomes (LDM), and Golgi deriv-
atives from total microsomes (10–12). Low-density microsomes
were separated by isopycnic density gradient centrifugation on
linear sucrose gradients (d1.05–1.25). Fractions were collected
from the top of the gradient, and equal volumes of each fraction
were analyzed for their content of PTPH1, JAK-2, Bip, and p97
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by immunoblot analysis followed by ECL revelation and visual-
ized by radioautography using Kodak X-Omat AR film. Quan-
titation was done by scanning densitometry. Results were nor-
malized according to the method of Beaufay et al. (17).
Reconstitution of tER was done in 0.25 ml containing 150 mg of
microsomal protein LDMy100 mM TriszHCl, pH 7.4y5 mM
MgCl2y1 mM GTPy2 mM ATPy0.1 mM DTTy0.02 mM PMSFy
0.09 mg ml21 leupeptiny50 mM sucrose. This mixture was
incubated at 37°C up to 240 min.
Morphological Analysis. After incubation, membranes were fixed
using 2.5% glutaraldehyde and recovered onto Millipore mem-
branes by the random filtration technique (18) and processed for
electron microscopy. Estimates of the lengths of embedded and
sectioned rough and smooth membranes in the membrane
networks were obtained from EM micrographs by morphometry
using the membrane intersection counting procedure (19). The
electron micrographs were fastened onto a measuring tablet
(Graphic Master, Numonics, Landsdale, PA), and the Sigma-
Scan measurement system (Jandel, San Rafael, CA) was used to
digitize morphometric data. The analyzed areas correspond to
the surface area of embedded and sectioned membrane pellicule
calculated on electron micrograph at low magnification (3550).
Five micrographs were counted for each sample in each of the
three independent experiments.
Protein Purification. Low-density microsomes from rat liver (600
mg to 5 mg) were solubilized in 3 to 15 ml of 30 mM TriszHCl,
pH 8.0y150 mM NaCly1.5% CHAPSy1 mM PMSFy100 mM
bpV(phen) (20, 21)y1 mg/ml leupeptiny5 kallikrein-inhibiting
units/ml aprotinin (buffer A) for 30 min. Lysate was centrifuged
for 30 min at 100,000 3 gav, and the supernatant was incubated
with ATP-agarose beads (Sigma). Beads were then extensively
washed with buffer A, and bound proteins were eluted by a step
gradient (from 150 mM NaCl to 900 mM NaCl). Each fraction
was then tested for the presence of kinase activity by incubation
with 0.5 mgyml poly Glu-Tyr in 30 mM TriszHCl, pH 8.0y150
mM NaCl (final concentration)y10 mM MgCl2y1 mCi
[g-32P]ATP. After reaction, substrates were spotted onto 3MM
filter paper and precipitated in 5% trichloroacetic acid, 1%
pyrophosphate. Filters were then washed extensively, and radio-
activity was measured by scintillation counting. Fractions con-
taining the highest specific activity were concentrated and either
in vitro autophosphorylated in 20 mM TriszHCl, pH 8.0y10 mM
MgCl2y5 mM MnCl2y1 mCi [g-32P]ATP for 20 min at 30°C, then
resolved by SDSyPAGE and radioautographed on X-Omat AR
films, or resolved by SDSyPAGE followed by immunoblotting
with anti-JAK-2 antibodies.
Pull-Down, Immunoprecipitation, in Vitro Phosphorylation. Cytosol
or LDM were incubated as described above in the presence or
in the absence of 100 mM bpV(phen) and 100 mCi [g-32P]ATP.
Phosphorylated samples were then solubilized in 25 volumes of
50 mM Hepes, pH 7.5y5 mM EDTAy1% Triton X-100y150 mM
NaCly10 mM sodium phosphatey0.5 mM DTTy50 mM NaFy5
mM iodoacetic acid, centrifuged at 100,000 3 g for 20 min, and
then incubated in the presence of glutathione-Sepharose beads
carrying 15 mg of GST-PTPH1 D811A mutant for 4 h at 4°C.
Beads were then pelleted and washed four times with the same
buffer. Proteins pulled-down were resolved by SDSyPAGE and
either immunoblotted with anti-p97 or anti-GST antibodies and
revealed by enhanced chemiluminescence or directly radioauto-
graphed to X-Omat AR films. JAK-2 or nonimmune serum
immunoprecipitates from LDM lysate (as described above) were
in vitro phosphorylated in 20 mM TriszHCl, pH 8.0y5 mM MgCl2
in the presence of 100 mCi [g-32P]ATP. Phosphorylated material
was either directly resolved by SDS-PAGE or released with 1%
SDS 50 mM TriszHCl, pH 8.0, for 10 min at 95°C and sequentially
immunoprecipitated with anti-p97 or anti-JAK-2 antibodies.
Results
We used a cell-free system to assess the relevance of tyrosine
phosphorylation of p97 in membrane fusion. This assay recon-
stitutes the assembly of 1.5-mm-diameter transitional ER net-
works from a starting preparation of low-density microsomes
(0.08–0.12-mm diameter). The assay requires ATP hydrolysis by
p97 and the t-SNARE syntaxin 5 for membrane fusion (12).
Tyrosine phosphorylation of endogenous p97 was demon-
strated using conditions that promote assembly of tER (12).
LDM (1.17 g cc21) from rat liver were incubated in the presence
of Mg21 GTP, Mg21 ATP, and the tyrosine phosphatase inhib-
Fig. 1. Tyrosine phosphorylation of p97. (A) LDM were incubated or not
using tER assembly conditions as previously described (10–12) in the presence
or absence of 100 mM bpV(phen). Solubilized membranes were immunopre-
cipitated either with antiphosphotyrosine antibodies (Ip: aPY, top gel) or with
anti-p97 antibodies (Ip: ap97, middle and lower gels) followed by immuno-
blotting using anti-p97 (Ib: ap97, top and bottom gels) or anti-phosphoty-
rosine antibodies (Ib: aPY, middle gel) and revealed by chemiluminescence
(ECL). A representative experiment is shown (n 5 4) with similar results
observed each time. (B) LDM were incubated in the same medium described
above but containing 100 mCi [g-32P]ATP and the absence or presence of either
100 mM bpV(phen) or 200 mM genistein. After p97 immunoprecipitation, the
proteins in the immunoprecipitate were separated by SDSyPAGE and trans-
ferred onto nitrocellulose membrane. The membrane was subjected to radio-
autographic analysis using X-Omat AR film (top gel), then probed with anti-
p97 and revealed by ECL (bottom gel). Densitometric analysis of the x-ray films
was performed, and the representation is the mean of three independent
experiments 6 SD for the three incubation conditions.
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itor bpV(phen) (20, 21). Immunoblot and immunoprecipitation
analysis revealed the tyrosine phosphorylation of p97 (Fig. 1A).
With an in vitro phosphorylation assay using intact membranes,
the same inhibitor enhanced the incorporation of 32P from
[g-32P]ATP into endogenous p97 (1.8-fold stimulation; Fig. 1B,
P , 0.001). Although less marked, the tyrosine kinase inhibitor,
genistein, reproducibly inhibited 32P incorporation into endog-
enous p97 (1.4-fold inhibition; Fig. 1B, P , 0.009). Hence, these
membranes contained endogenous kinase(s) and phosphatase(s)
responsible for phosphorylation and dephosphorylation of p97
on tyrosine residue(s).
The identity of candidate kinase(s) responsible for the ty-
rosine phosphorylation of p97 in LDM was investigated by
ATP-agarose chromatography of LDM lysates. Fractions were
eluted by an NaCl step gradient and tested for tyrosine kinase
activity with poly Glu-Tyr as substrate (Fig. 2A, graph). The
fractions extracted with 0.45 and 0.6 M NaCl, which contained
the highest tyrosine kinase specific activity (Fig. 2 A, graph),
were pooled, concentrated, dialyzed, and then analyzed by
SDSyPAGE after in vitro autophosphorylation with [g-32P]ATP.
Only one major autophosphorylated band with a mobility cor-
responding approximately to 130 kDa was detected (Fig. 2 A,
Right, lane 1, arrowhead).
After screening with different antibodies raised against pro-
tein tyrosine kinases with a comparable molecular mass, immu-
noblotting revealed JAK-2 in the purified fraction from LDM
(Fig. 2 A, Right, lane 2). After JAK-2 immunoprecipitation from
solubilized LDM and in vitro phosphorylation with [g-32P]ATP,
seven radiolabeled polypeptides were observed in the immuno-
precipitates, which were not in a nonimmune immunoprecipitate
(Fig. 2B, lane 4). One corresponded to the mobility of JAK-2
(downward pointing arrow, Fig. 2B, lane 1) and one to that of p97
(upward pointing arrow). The identity of the phosphoproteins
migrating at 130 and 97 kDa as JAK-2 and p97, respectively, was
confirmed by sequential immunoprecipitations (Fig. 2B, lanes 2
and 3, respectively). JAK-2 associated phosphoproteins were
Fig. 2. Purification of tyrosine kinase activities from LDM. (A) Low-density
microsomes from rat liver (600 mg to 5 mg) solubilized were incubated with
ATP-agarose beads. Eluted fractions were then tested for the presence of
kinase activity by incubation with 0.5 mgyml poly Glu-Tyr, and radioactivity
was measured by scintillation counting. Protein concentration was measured
for each fraction and is reported on the graph. L represents 5% of total protein
lysate chromatographed on ATP-agarose. Fractions containing the highest
specific activity were concentrated and either in vitro autophosphorylated
(Right, lane 1) or directly resolved by SDSyPAGE followed by immunoblotting
with anti-JAK-2 antibodies (Right, lane 2). (B) In vitro phosphorylation of
JAK-2 immunoprecipitate from LDM (lane 1, overnight exposure) or in vitro
phosphorylation of JAK-2 immunoprecipitate from LDM, followed by release
and sequential immunoprecipitation with anti-JAK-2 antibodies (lane 2, over-
night exposure) or anti-p97 antibodies (lane 3, 40-h exposure). In lane 4, a
nonimmune serum (NI) was used in the primary immunoprecipitation, and an
anti-p97 was used for the secondary immunoprecipitation (overnight expo-
sure). (C) In vitro phosphorylation of 10 mg of myelin basic protein (MBP, lane
1) or purified p97 (lane 2) by JAK-2 immunocomplex from LDM. A represen-
tative experiment is shown (n 5 2).
Fig. 3. Identification of p97 tyrosine phosphatase from low-density micro-
somes. (A) Cytosol or LDM were incubated as described above in the presence
or in the absence of 100 mM bpV(phen) and 100 mCi [g-32P]ATP. Lysates were
then incubated in the presence of glutathione-Sepharose beads carrying 15
mg of GST-PTPH1 D811A mutant for 4 h at 4°C. Proteins pulled-down were
resolved by SDSyPAGE and either immunoblotted with anti-p97 or anti-GST
antibodies and revealed by enhanced chemiluminescence (Middle and Bot-
tom) or directly radioautographed to X-Omat AR films (Top). A representative
experiment is shown (n 5 3). (B) Analytical fractionation by isopycnic density
gradient centrifugation of LDM. Each fraction was tested for its content p97,
PTPH1, JAK-2, and Bip by immunoblotting. Quantitation was done as de-
scribed under Experimental Procedures.
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released by SDS at 95°C followed by immunoprecipitation with
anti-JAK-2 or anti-p97 antibodies. This revealed single phos-
phoproteins at 130 and 97 kDa, respectively (Fig. 2B, lanes 2 and
3). When JAK-2 immunoprecipitates were immunoblotted with
anti-p97 antibodies, the same band at 97 kDa was visualized
(data not shown). The JAK-2 immunoprecipitate from LDM
phosphorylated the exogenous substrate myelin basic protein
(Fig. 2C, lane 1) as well as p97 purified from rat liver cytosol (Fig.
2C, lane 2). Taken together, these results identify JAK-2 as an
endogenous kinase of LDM that associates with and phosphor-
ylates endogenous p97.
Recently, p97 has also been identified as the major substrate
for the PTPase PTPH1 using a substrate-trapping strategy (16,
22). In this approach, the invariant aspartate residue of the PTP
signature motif, which facilitates protonation of the tyrosyl
Fig. 4. Effect of bpV(phen) and genistein on transitional ER assembly. LDM
(A) were incubated using assembly conditions as previously described (B) in
the presence of 100 mM bpV(phen) (C) or 350 mM genistein (D) for 180 min at
37°C. After the incubation, membranes were fixed and processed for electron
microscopy. rm, rough membrane; st, smooth tubules. Scale bars represent 0.5
mm. (E) Morphometric studies of the amount of rough endoplasmic reticulum
and smooth endoplasmic reticulum membranes in tER networks reconstituted
in presence or absence of 100 mM bpV(phen) or 350 mM genistein. Average
values (6SD) are shown from three separate experiments. RER, rough endo-
plasmic reticulum; SER, smooth endoplasmic reticulum. (F) Amount of tER
assembly per total membrane reconstituted in presence or absence of 100 mM
bpV(phen) or 350 mM genistein. Average values (6SD) are shown from three
separate experiments. The mean number of networks was not significantly
different when compared between control and DMSO (P . 0.05, n 5 21) but
was significantly different when compared between control and bpV(phen)
(P , 0.005, n 5 27) or DMSO and genistein (P , 0.001, n 5 20). The amount of
tER networks counted was as follows: control, 112 networks on 13 micro-
graphs; bpV(phen), 50 networks on 14 micrographs; DMSO, 90 networks on 8
micrographs; and genistein, 219 networks on 12 micrographs. Results were
expressed as average number of tER networks per 200 mm2 of membrane
pellicules.
Fig. 5. (A) Association of p97 to the membranes is regulated by its tyrosine
phosphorylation. LDM were incubated as previously described (10–12) in the
presence or absence of 100 mM bpV(phen) or 350 mM genistein for different
periods. The samples were then placed on ice and received 1 ml each of 0.25
M sucrose containing 3 mM imidazole. The samples were then centrifuged at
100,000 3 g for 30 min. The proteins in the membrane pellets were dissolved
directly in Laemmli buffer. The proteins in the supernatant fractions were
concentrated by trichloroacetic acid precipitation. Proteins were then sepa-
rated by SDSyPAGE, followed by immunoblotting with anti-p97 antibodies.
(B) Densitometric analysis of the above immunoblots. Each value is the mean
of three independent experiments 6 SD. Closed symbols stand for membrane-
associated p97 and open symbols for p97 released from the membranes,
respectively, l,L CTL;,, genistein; n ,h, bpV(phen). (C) LDM (600 mg) were
first incubated 45 min on ice as previously described, except that Hepes was
replaced by 6 mM imidazole, pH 7.4; this incubation buffer contained or not
350 mM genistein or 30 mg of GST-PTPH1 or GST-PTPH1D811A or 100 mM
bpV(phen). Microsomes were then solubilized in the same buffer containing
1.5% CHAPS. After spinning in a microfuge for 15 min at maximal speed,
lysates were immunoprecipitated with anti-p97 antibodies. Immunoprecipi-
tates were then resolved by SDSyPAGE, transferred onto nitrocellulose, and
immunoblotted with either anti-syntaxin 5 antibodies or anti-p97 antibodies
and revealed by ECL. A representative experiment is shown (control, genistein,
bpV(phen), and GST-PTPH1DA, n 5 3; GST-PTPH1, n 5 2). Quantitation was
made by scanning densitometry of the x-ray films and represents the mean 6
SD (when n 5 3); * indicates significant values P , 0.04. For syntaxin 5, the
intensities corresponding to the three bands visualized were added. (D)
Representative scheme of the sequence of events regulating p97 association
with LDM.
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leaving group and hydrolysis of the cysteinyl-phosphate inter-
mediate, respectively, is mutated to alanine. This mutation
dramatically slows catalysis without affecting ligand affinity,
allowing the identification of the major substrates of PTPH1. An
association of the tyrosine-phosphorylated p97 with this sub-
strate-trapping mutant of PTPH1 (PTPH1 D811A) (16) was
observed in the membranes used here (Fig. 3A). The experi-
mental design was to phosphorylate LDM in vitro by endogenous
kinases with endogenous PTPases inhibited by bpV(phen). A
GST-PTPH1 D811A was then used to trap any PTPH1 substrate
after inactivation of bpV(phen). Three bands were observed on
the radioautogram, with one band migrating at a mobility
corresponding to 97 kDa. This was confirmed as p97 by immu-
noblotting (Fig. 3A Middle). These studies predict PTPH1 as the
membrane-associated phosphatase responsible for p97 dephos-
phorylation. An assessment of the distribution of PTPH1 in
LDM was attempted by analytical fractionation. LDM were
separated on a linear sucrose gradient (density 1.05 to 1.28).
Fractions were analyzed by immunoblotting with antibodies
against PTPH1, JAK-2, p97, and Bip. PTPH1, JAK-2, and p97
revealed similar median densities, respectively, of 1.160, 1.164,
and 1.162 (Fig.3B), which corresponded to that of Syntaxin 5 as
previously reported (12). The ER marker Bip revealed a similar
distribution with a median density of 1.169, whereas the protein
content showed a median density of 1.161. We conclude that the
tyrosine kinase JAK-2, the tyrosine phosphatase PTPH-1, and
their substrate p97 are present in the same subcompartment of
the tER.
P97 has been previously implicated in membrane fusion leading
to tER assembly in vitro (12). Hence, the role of p97 phosphory-
lation was assessed using in vitro tER reconstitution as a read out.
BpV(phen) inhibited the assembly of the smooth tubule domain
within tER networks, thereby implicating a PTPase (Fig. 4 A–C);
similar results were obtained by incubating LDM with anti-
phosphotyrosine antibodies (data not shown). Smooth tubular
membranes associated with the reconstituted tER networks were
reduced 6-fold following incubation in the presence of bpV(phen)
(Fig. 4E). Furthermore, the total number of tER networks was
significantly decreased compared with control (Fig. 4F). In con-
trast, the tyrosine kinase inhibitor, genistein, did not affect signif-
icantly the amount of smooth membranes associated with any single
tER network (Fig. 4 D and E) but increased 2.5 times the total
number of tER networks (Fig. 4F).
Hence, genistein induced membrane fusion and coincidentally
increased the amount of nonphosphorylated p97. Dissociation of
p97 from membranes was accelerated in the presence of the
PTPase inhibitor bpV(phen), whereas in the presence of
genistein, p97 dissociation from membranes was inhibited (Fig.
5 A and B). Although p97 is serine phosphorylated by p34cdc2
(23), no effect on the SeryThr phosphatases inhibitor, okadaic
acid (10–30 mM), was observed (data not shown).
P97 has been found in a complex with p47 and syntaxin 5 (24).
Following solubilization of reconstituted tER after incubation in
the presence or not of 350 mM genistein, or 30 mg of GST-PTPH1,
p97 association with syntaxin 5 was evaluated by coimmune pre-
cipitation. Minimal stable association of p97 and syntaxin 5 was
found under conditions used to generate tER networks (Fig. 5C,
control). However, association was enhanced (4- to 5-fold) after
incubation in the presence of genistein or GST-PTPH1, whereas
the amount of p97 immunoprecipitated remained the same (Fig.
5C). We observed also that incubation with 100 mM bpV(phen)
abolished completely the association of p97 with syntaxin 5 (data
not shown). Hence, preventing tyrosine phosphorylation of p97 or
increasing its dephosphorylation enhanced the steady-state stability
of p97 (and p47):syntaxin 5 complexes, which coincided with an
enhanced number of tER networks.
Discussion
The present study is the first to demonstrate JAK-2 and PTPH1
as ER-associated constituents implicated in tER formation. This
was deduced from a cell-free system that faithfully reconstitutes
cargo sorting as well as enhanced tER concentration of the
recycling membrane proteins a2p24 and p58 (ERGIC 53) (25).
The starting membrane preparation (LDM) has been docu-
mented as ER derived with little contamination from the plasma
membrane or the Golgi apparatus (11, 12). LDM are isolated
from liver parenchyma of young adult rats. These cells are largely
in G0 (26), and the events described here are therefore unlikely
to be related to the postmitotic assembly of tER. Moreover, p97
accumulates in nonproliferating cells and is not detectable in
proliferating cells in Drosophila (27, 28). Genetic studies have
shown that the p97 ortholog and the putative p47 ortholog
Bag-of-marbles are involved in membrane fusion events (27).
Therefore, the reconstitution of the differentiated early secre-
tory pathway by fusion of fragmented LDM likely reflects
dynamic membrane transformation events of the early secretory
apparatus. PTPH1 and JAK-2 share a band 4.1-related domain
at their N-termini (29–31). This domain has been implicated in
targeting proteins to the membraneycytoskeleton interface (32),
but it may also be a motif for directing association with the tER
membrane because of its low affinity for phosphatidylinositol
(4,5)P2 (33). Indeed, phosphatidylinositol (4,5)P2 is known to be
synthesized in the ER membrane (34) and has also been shown
to regulate homotypic vacuole membrane fusion events in yeast
(35). The effect of genistein on membrane fusion observed in
this study could also be linked to its role in phosphatidylinositol
turnover.
These data indicate a relationship between signal transduction
events (tyrosine phosphorylation) and SNARE-regulated fusion
and extend the signal transduction pathways to membrane
elements of the early secretory pathway. Tyrosine phosphory-
lation does not affect the ATPase activity of p97 (36). Thus, the
regulation of its localization in proximity to the fusogenic
apparatus is likely relevant to SNARE priming (Fig. 5D).
Dephosphorylation of p97 stabilized p97 (and p47):syntaxin 5
association. A similar scenario has been observed for a-SNAP,
whose phosphorylation by protein kinase A decreased the
SNARE binding capacity of N-ethylmaleimide sensitive fac-
tor:a-SNAP complexes (37). In our assay, dephosphorylation of
p97 was linked to membrane association of the ATPase through
stabilization of the p97 (and p47):syntaxin 5 complexes. This
coincided with an enhanced number of fusogenic events that
would be a predicted outcome of enhanced docking of smooth
membrane vesicles in LDM to reconstituting rough cisternae,
leading to an increased number of tER networks (Fig. 4).
Phosphorylationydephosphorylation of p97 may be a means of
controlling the number of rounds of fusion ultimately limiting
the size of the tER compartment, which is known to vary widely
within different cell types (3, 7–9).
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